Dias I

References (3)

Title : Exploiting the potential of rivastigmine-melatonin derivatives as multitarget metal-modulating drugs for neurodegenerative diseases - Dias_2024_J.Inorg.Biochem_262_112734
Author(s) : Dias I , Bon L , Banas A , Chavarria D , Borges F , Guerreiro-Oliveira C , Cardoso SM , Sanna D , Garribba E , Chaves S , Santos MA
Ref : J Inorg Biochem , 262 :112734 , 2024
Abstract :
PubMedSearch : Dias_2024_J.Inorg.Biochem_262_112734
PubMedID: 39378762

Title : New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease - Bon_2024_Pharmaceutics_16_
Author(s) : Bon L , Banas A , Dias I , Melo-Marques I , Cardoso SM , Chaves S , Santos MA
Ref : Pharmaceutics , 16 : , 2024
Abstract :
PubMedSearch : Bon_2024_Pharmaceutics_16_
PubMedID: 38399339

Title : Synthesis, molecular docking and preliminary evaluation of 2-(1,2,3-triazoyl)-benzaldehydes as multifunctional agents for the treatment of Alzheimer's disease - Costa_2020_ChemMedChem__
Author(s) : Costa GP , Baldinotti R , Fronza MG , Nascimento JE , Dias I , Sonego MS , Seixas FK , Collares T , Perin G , Jacob RG , Savegnago L , Alves D
Ref : ChemMedChem , : , 2020
Abstract :
PubMedSearch : Costa_2020_ChemMedChem__
PubMedID: 32012463